Results: NVIDIA Corporation Exceeded Expectations And The Consensus Has Updated Its Estimates
by admin •
A week ago, NVIDIA Corporation (NASDAQ:NVDA) came out with a strong set of first-quarter numbers that could…
Nvidia Sinks Despite Stellar Earnings; Top Analyst Says Buy On Any Weakness
by admin •
Nvidia (NVDA) has posted stellar earning results for the fiscal first quarter, although shares moved marginally lower in Thursday’s after-hours trading due to weaker-than-expected guidance. Income doubled from the same period last year, with Q1 Non-GAAP EPS of $1.80 beating the Street by $0.12, and GAAP EPS of $1.47 also topping expectations by $0.10.Revenue of $3.08B represented…
Goldman Says Buy World’s Worst Stock Market Because Rebound Is Coming
by admin •
(Bloomberg) — Goldman Sachs is bullish on the world’s hardest-hit stock market.Down more than 48% this year when measured in dollars, Brazilian stocks will benefit from growing appetite for risky assets and a recovery in commodities prices during the second half of 2020, strategists led by Kamakshya Trivedi wrote in a report dated May 20.“Brazilian…
Moderna Stock Volatile Amid Work on Coronavirus Vaccine
by admin •
Moderna, Inc. (NASDAQ:MRNA) stock popped after positive news about the company's coronavirus vaccine candidate. After the shares climbed 20% to record highs, the company announced plans to sell $1.25 billion in new shares to fund manufacturing and distribution of its vaccine candidate. Update on Moderna's coronavirus vaccine Moderna's coronavirus vaccine is officially referred to as…
Here's How Much Investing $1,000 In The 2014 Alibaba IPO Would Be Worth Today
by admin •
Investors who owned stocks in the past five years generally experienced some big gains. In fact, the SPDR S&P 500 (NYSE: SPY) total return since Sept. 18, 2014 is 64.2%. But there's no question some big-name stocks did much better than others along the way.Alibaba's Big DebutOne market leader since its 2014 IPO is Chinese…
Stocks Fall After Moderna Vaccine Study Questioned: Markets Wrap
by admin •
(Bloomberg) — U.S. stocks fell for the first time in four sessions after reports circulated that Moderna Inc.’s vaccine study, which was credited in part for Monday’s rally, didn’t produce enough critical data to assess its success. Crude oil and Treasuries gained.The S&P 500 and Nasdaq Composite turned negative in the last hour of trading,…
Novavax Seeks To Raise $250 Million From Share Sale; Top Analyst Bumps Up PT
by admin •
Novavax (NVAX) filed a prospectus to sell up to $250 million of shares of common stock as it prepares to scale up production of its coronavirus vaccine candidate.Shares in Novavax jumped 31% to close at $56.96 in U.S. trading on Monday after their value more than doubled over the past month.The late-stage biotech company, which…
Grim warnings from Powell and the Fed push rates on home loans to new low
by admin •
All the gloom coming from the Federal Reserve has sent mortgage rates even lower.
The Fed issues a warning about the stock market: Morning Brief
by admin •
Top news and what to watch in the markets on Monday, May 18, 2020.
Warren Buffett says this is how to financially survive COVID-19
by admin •
The billionaire investing guru has these money tips for the coronavirus crisis.
Gilead to end coronavirus drug trials, adding to access worry -researchers
by admin •
Gilead Sciences Inc's two clinical studies of its potential coronavirus treatment remdesivir will wind down by the end of May, closing off a path of patient access to the antiviral medication, according to U.S. researchers involved in the studies. The drug was given emergency use authorization by the U.S. Food and Drug Administration on May…